S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

770

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

July 31, 2006

Study Completion Date

January 31, 2007

Conditions
Prostate Cancer
Interventions
DRUG

docetaxel

DRUG

estramustine

DRUG

mitoxantrone

DRUG

prednisone

Trial Locations (16)

32224

Mayo Clinic, Jacksonville

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Health Plaza, Saint Cloud

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58201

Altru Health System, Grand Forks

58501

Medcenter One Health System, Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Cancer and Leukemia Group B

NETWORK

collaborator

North Central Cancer Treatment Group

NETWORK

lead

SWOG Cancer Research Network

NETWORK

NCT00004001 - S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter